Thiele C - Search Results

1

Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene.

Tsao H, Benoit E, Sober AJ, Thiele C, Haluska FG. Tsao H, et al. Among authors: thiele c. Cancer Res. 1998 Jan 1;58(1):109-13. Cancer Res. 1998. PMID: 9426066

2

Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines.

Haluska FG, Thiele C, Goldstein A, Tsao H, Benoit EP, Housman D. Haluska FG, et al. Among authors: thiele c. Int J Cancer. 1997 Jul 17;72(2):337-9. doi: 10.1002/(sici)1097-0215(19970717)72:2<337::aid-ijc22>3.0.co;2-b. Int J Cancer. 1997. PMID: 9219842

3

In vitro activation of distinct molecular and cellular phenotypes after induction of differentiation in a human neuroblastoma cell line.

Gaetano C, Matsumoto K, Thiele CJ. Gaetano C, et al. Among authors: thiele cj. Cancer Res. 1992 Aug 15;52(16):4402-7. Cancer Res. 1992. PMID: 1322787

4

Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors.

Cohen PS, Cooper MJ, Helman LJ, Thiele CJ, Seeger RC, Israel MA. Cohen PS, et al. Among authors: thiele cj. Cancer Res. 1990 Sep 15;50(18):6055-61. Cancer Res. 1990. PMID: 2393870

5

Increased N-myc expression following progressive growth of human neuroblastoma.

Rosen N, Reynolds CP, Thiele CJ, Biedler JL, Israel MA. Rosen N, et al. Among authors: thiele cj. Cancer Res. 1986 Aug;46(8):4139-42. Cancer Res. 1986. PMID: 3731081

6

Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.

Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ. Matsumoto K, et al. Among authors: thiele cj. Cancer Res. 1995 Apr 15;55(8):1798-806. Cancer Res. 1995. PMID: 7712490

7

Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.

Scala S, Wosikowski K, Giannakakou P, Valle P, Biedler JL, Spengler BA, Lucarelli E, Bates SE, Thiele CJ. Scala S, et al. Among authors: thiele cj. Cancer Res. 1996 Aug 15;56(16):3737-42. Cancer Res. 1996. PMID: 8706017

8

MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors.

Jaboin J, Wild J, Hamidi H, Khanna C, Kim CJ, Robey R, Bates SE, Thiele CJ. Jaboin J, et al. Among authors: thiele cj. Cancer Res. 2002 Nov 1;62(21):6108-15. Cancer Res. 2002. PMID: 12414635

9

Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.

Jaboin J, Kim CJ, Kaplan DR, Thiele CJ. Jaboin J, et al. Cancer Res. 2002 Nov 15;62(22):6756-63. Cancer Res. 2002. PMID: 12438277

10

Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.

Yang X, Merchant MS, Romero ME, Tsokos M, Wexler LH, Kontny U, Mackall CL, Thiele CJ. Yang X, et al. Cancer Res. 2003 Mar 1;63(5):1122-9. Cancer Res. 2003. PMID: 12615731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters